| Identification | |
|---|---|
| Name | 1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide |
| Accession Number | DB06896 |
| Type | small molecule |
| Description | Not Available |
| Structure |
|
| Categories (*) | |
| Molecular Weight | 458.4163 |
| Groups | experimental |
| Monoisotopic Weight | 458.119046808 |
| Pharmacology | |
| Indication | Not Available |
| Mechanism of action | Not Available |
| Absorption | Not Available |
| Protein binding | Not Available |
| Biotransformation | Not Available |
| Route of elimination | Not Available |
| Toxicity | Not Available |
| Affected organisms | Not Available |
| Interactions | |
| Drug Interactions | Not Available |
| Food Interactions | Not Available |
| Hepatocyte growth factor receptor | |
|---|---|
| Name | Hepatocyte growth factor receptor |
| Gene Name | MET |
| Pharmacological action | unknown |
| Actions | Not Available |
| References |
|
| DTHybrid score | 1.74 |
| Id | Partner name | Gene Name | Score |
|---|---|---|---|
| 990 | Dual specificity mitogen-activated protein kinase kinase 1 | MAP2K1 | 0.0869 |
| 4177 | Proto-oncogene tyrosine-protein kinase receptor ret | RET | 0.0357 |
| 407 | Vascular endothelial growth factor receptor 2 | KDR | 0.0289 |
| 4757 | Cytochrome P450 2C9 | CYP2C9 | 0.0125 |
| 4512 | Cytochrome P450 3A4 | CYP3A4 | 0.0111 |